Kindred Biosciences, Inc.
Kindred Biosciences, Inc. (KIN) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 175 transactions totaling $472.9M, demonstrating a bullish sentiment with $450.9M in net insider flow. The most recent transaction on Aug 27, 2021 involved a purchase of 45,508,938 shares valued at $421.0M.
KIN Insider Activity Summary
Who Is Buying KIN Stock?
No significant insider buying has been recorded for KIN in the recent period.
Who Is Selling KIN Stock?
No significant insider selling has been recorded for KIN in the recent period.
Is Kindred Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KIN is bullish with an Insider Alignment Score of 98/100 and a net flow of $450.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KIN Frequently Asked Questions
Understanding KIN Insider Activity
Insider trading at Kindred Biosciences, Inc. (KIN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading KIN stock, having executed 175 transactions in the past 90 days. The most active insider is Animal Health Inc Elanco (Executive), who has made 1 transactions totaling $421.0M.
Related Tools
Track Kindred Biosciences, Inc. Insider Activity
Get notified when executives and directors at KIN file new Form 4 transactions